Diagnostic and Biotech

In Vitro Diagnostics (IVD) Asia-Pacific Market - Opportunities and Forecasts, 2014 - 2020

  • ALL563815
  • 180 Pages
  • March 2016
  • Diagnostic and Biotech

In vitro diagnostics (IVD) are diagnostic tests practiced in an artificial environment. The overall revenue of the Asia-Pacific IVD market accounted for about $10.7 billion in 2014, and is estimated to reach $15.3 billion by 2020, registering a CAGR of 6.5% over the forecast period. Considerable increase in the number of chronic and infectious diseases, growing awareness towards healthcare solutions and technological advancements in healthcare industry largely supplement the growth of this market. However, stringent regulatory policies and reimbursements issues in few countries limit the growth of this market. The rising demand for technologically advanced diagnostic devices, rise in GDP and per capita income and rise in disposable incomes facilitate a huge potential for the IVD market in the Asia-Pacific region.

The Asia-Pacific IVD market is segmented based on technique, product type, usability, application, end user and country. Based on technique, the market is segmented into immunoassays, clinical chemistry, point-of-care, molecular diagnostics, hematology, coagulation, microbiology and other clinical techniques. Point-of-care is the highest revenue-generating segment in the overall IVD techniques market. However, the molecular diagnostics is the fastest growing technique in the overall IVD techniques market due to its ability to accurately detect the primary cause of the disease.
Based on product type, the market is segmented into instruments, reagents, data management systems and services. Instruments segment holds the highest market share in the Asia-Pacific IVD market followed by rapidly growing reagents segment. Reagents are largely used in various equipment and play a key role in the overall diagnosis process. The usability segment is classified as disposable and reusable IVD devices. Doctors and clinicians largely prefer disposable devices to avoid infections; generating larger revenue in comparison to reusable devices. The application segment is categorized into infectious diseases diabetes, cancer/oncology, cardiology, autoimmune diseases, nephrology, drug testing, HIV/AIDS and others. Infectious diseases was the highest revenue-generating segment in 2014 and would continue to maintain its position throughout 2020, due to the rise in incidences of infectious diseases.

Hospitals and laboratories, academics, point-of-care testing and others form the end users segment in the Asia-Pacific IVD market. Hospitals and laboratories generate the highest revenue, followed by point-of-care. A significant rise in the number of hospitals and laboratories across the Asia-Pacific region along with increased awareness about developments in healthcare largely contribute to the growth of this segment.

Based on country, the Asia-Pacific IVD market is segmented into India, China, Japan, Australia, South Korea and rest of the Asia-Pacific. Currently, China leads the Asia-Pacific IVD market, owing to the high demand for testing in outpatient clinics, huge population base and rising medical insurance services by the Chinese government. However, Australia and South Korea hold the significant market share due to the well-supported reimbursement facilities and well-regulated IVD devices, which comes under the regulation of medical devices.
Key companies profiled in this market include Danaher Corporation, Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Alere Inc., Affymetrix Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, BioMerieux, Vela Diagnostics and others. Product launch and technological advancements are the few strategies adopted by the key players of IVD market. The companies are currently focusing on innovative technologies such as automated and point-of-care IVD devices.

KEY BENEFITS:

  • Extensive coverage of the Asia-Pacific IVD market including drivers, restraints and opportunities would help professionals to better understand the market behaviour
  • The projections in the report are made by analyzing the current market trends and market potential for the period of 20142020
  • A comprehensive analysis of the market scenario in terms of technologies, applications, usability, product type end users and geography helps identify the growth opportunities in the Asia-Pacific IVD market
  • The market attractiveness analysis for the Asia-Pacific IVD market provides strategic assistance to the decision makers
  • Key market players within the Asia-Pacific IVD market are profiled in the report and their strategies are analysed thoroughly, which helps in understanding competitive outlook of this market

IN VITRO DIAGNOSTICS MARKET KEY SEGMENTS:

Asia-Pacific IVD market is segmented into applications, technology, product type, usability, end user, and geography.

By Techniques

  • Immunoassays
  • Clinical Chemistry
  • Point Of Care
  • Microbiology
  • Molecular Diagnostics
  • Whole Blood Glucose
  • Hematology
  • Coagulation
  • Other clinical techniques

By Product Type

  • Instruments
  • Reagents
  • Data management systems
  • Services

By Usability

  • Disposable Devices
  • Reusable Devices

By Applications

  • Infectious Diseases
  • Diabetes
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Diseases
  • Nephrology
  • Drug Testing
  • HIV/AIDS
  • Others

By End-User

  • Hospitals and Laboratories
  • Academics
  • Point of Care Testing
  • Others

By Countries

  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Others
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

European NGS Services Market - Opportunities and Forecasts, 2015 - 2020

Next Generation Sequencing (NGS) services, also known as high-throughput sequencing, is term used to describe sequencing technologies, such as Illumina sequencing, Roche 454 sequencing, and SOLiD sequencing. These technologies enable ...

January 2018| $3390 | Pre Book Price:$2967

World Surface Analysis Market - Opportunities and Forecasts, 2014 - 2020

Surface analysis is a technique that provides a medium to correlate performance with thin film conformation. The analysis is used in the discovery of new materials and to enhance the ...

January 2018| $5370 | Pre Book Price:$4699

World Electrophoresis Market - Opportunities and Forecasts, 2015 - 2020

Electrophoresis is a technique used for separation of proteins and nucleic acids. This technique is primarily used for RNA and DNA analysis. It is also used in biochemistry for separation ...

January 2018| $5370 | Pre Book Price:$4699

World Oxidative Stress Assay Market - Opportunities and Forecasts, 2015 - 2020

Oxidative stress assay is used to determine level of oxidative stress markers and reagents in cells. Applications of oxidative stress assay are research laboratories and bioproduction. Assays detect generalized oxidative ...

January 2018| $5370 | Pre Book Price:$4699

European Microscopy Market - Opportunities and Forecasts, 2015 - 2020

Microscopy is a field of science in which objects are not visible to bare eye can be viewed under microscope. It is used to observe macromolecules and macromolecular complexes at ...

January 2018| $3390 | Pre Book Price:$2967

World Immunoassay Market - Opportunities and Forecasts, 2015 - 2020

Immunoassay is a test conducted to determine concentration of macromolecule in a solution using antibody or immunoglobulin. The macromolecule detected is known as analyte. Immunoassay is used to measure quantity ...

January 2018| $5370 | Pre Book Price:$4699

2017 © Copyright Big Market Research

View Pricing >>